Debate synthesis

Post-Debate Synthesis

Issue 1: Necessity vs. sufficiency of K82 acetylation as the causal driver of mislocalization

Manuscript evidence: K82Q acetylation-mimic blocks nuclear import and importin-α1 binding in neurons (Fig. 3C–E); synthetic K82-acetylated peptides (not mimics) abolish importin-α1 binding in vitro while K79/K84-acetylated and phosphorylated peptides only reduce it (Fig. 3F); no experiment blocks endogenous acetylation and tests whether nuclear import is rescued under proteasome inhibition.

Skeptic's case: Every load-bearing experiment shows a mimic or isolated peptide is sufficient to disrupt import; none shows acetylation is necessary for the mislocalization seen under proteasome inhibition. This mirrors a concern raised independently across three specialist reports (scientific_validity, data_analysis, reporting_reproducibility), each proposing a version of the same missing control (acetylation-resistant rescue construct, K82Q-vs-BTZ functional comparison, endogenous ac-K82 co-IP). The skeptic characterizes this as one missing experiment described five ways, not independent corroboration, but argues the convergence on which experiment is missing is itself informative. The title ("initiates... by disrupting nuclear import") makes an unhedged causal/necessity claim that the abstract's own hedge ("plausible initiator") does not support, creating a claim–evidence mismatch on the paper's most consequential claim.

Advocate's case: The proposed "clean" necessity experiment (K79R/K82R/K84R combined mutant, rescue-under-inhibition) is not actually interpretable given the paper's own data: Fig. 4C–E shows K82R alone (a non-acetylatable but charge-preserving substitution) independently disrupts importin-α1 binding and causes mislocalization, meaning any acetylation-resistant construct built on K82R would be confounded by the mutation itself, not by loss of acetylation per se. Given this structural constraint, the peptide-acetylation experiment (Fig. 3F) is the most direct causal test available, and it examines genuine acetylation rather than a mimic.

Where it stands: Partially resolved, partially unresolved. The advocate's rebuttal is conceded by the skeptic to strengthen the sufficiency claim (K82Q accurately reflects real acetylation) but does not answer the necessity gap — no experiment in the manuscript shows blocking acetylation rescues import under physiological proteasome decline. The debate did not resolve whether an alternative, non-confounded necessity experiment is feasible (e.g., pharmacological deacetylation, or a different residue substitution strategy); this remains open. Both sides agree the fix is tractable (one additional experiment) rather than requiring new theory. The disagreement that persists is whether the current sufficiency-only evidence, given the structural confound, is enough to support the title's causal framing, or whether the title/abstract language needs revision to match sufficiency/correlational evidence as-is. Not fatal — both debaters treat this as fixable via either new data or reframed claims, not as invalidating the mechanistic finding itself.

Issue 2: Acetylation "precedes phosphorylation" (temporal ordering claim, Fig. 5C)

Manuscript evidence: Ac-K82 detected in both soluble and insoluble fractions of sALS motor cortex; phosphorylated TDP-43 detected only in insoluble fraction.

Case: This point was raised independently in two specialist reports (reporting_reproducibility, contribution_context) and was not contested in the debate — both debaters treated it as a valid criticism. The skeptic explicitly folds it into the causal-overreach case, arguing solubility fractionation is not a temporal assay and that the claim should be softened or removed rather than merely hedged, since (per contribution_context and reporting_reproducibility) the observation conflates subcellular compartmentalization with temporal sequence, and no kinetic or co-modification data are offered to support precedence.

Where it stands: Unresolved as a point of contention only in the sense that no rebuttal was offered — the advocate did not dispute it. Effectively conceded. Editor should treat this as a claim requiring softening or removal, independent of the necessity/sufficiency debate above.

Issue 3: Title/abstract framing vs. evidence scope

Case: The skeptic argues the title's causal verb ("initiates") is inconsistent with the abstract's own hedged language ("plausible initiator") and that a reader relying on the title and Fig. 3 alone would conclude causality has been established when it has not. The advocate concedes this point directly ("I'll concede the title's 'initiates' oversells relative to the abstract's own carefully hedged language... worth softening in revision").

Where it stands: Resolved by concession. Both sides agree this is a wording/framing issue distinct from the underlying necessity question, fixable through revision without new experiments.

Issue 4: Ethics — missing IACUC statement and funding/competing-interests declaration

Raised only in the ethics report (mouse cortex data in Fig. S1A lack any stated animal-protocol approval; no funding or competing-interests statement anywhere in the manuscript). The skeptic explicitly raised these in the debate, calling them "real omissions requiring correction before publication" but not scientifically fatal. Not contested by the advocate. Resolved as non-fatal but required corrections — both sides agree these are administrative gaps, not evidence problems, but the ethics reviewer flagged them as HARD issues that need addressing prior to publication.

Concerns raised in reports but not engaged in the debate

The debate concentrated almost entirely on the necessity/sufficiency and temporal-ordering issues. The following substantive concerns from the specialist reports were not discussed and should not be read as resolved:

• Lack of multiple-comparison correction in the TMT proteome analysis (Fig. 1E–F), and whether TDP-43 remains the top hit after correction (data_analysis).
• Small, clinically unannotated sALS cohort (n=6) with no correlation of ac-K82 levels to disease duration, severity, or phospho-TDP-43 burden (contribution_context, scientific_validity, reporting_reproducibility — a genuine repeated concern, not independent corroboration given shared underlying model).
• Acetylation-specific antibodies validated only by ELISA against synthetic peptides, without orthogonal (mass-spec or blocking-peptide) validation in tissue lysate (data_analysis, reporting_reproducibility, scientific_validity — again convergent wording of the same concern).
• No identification of the acetyltransferase/deacetylase responsible for K82 acetylation, leaving the proteasome→acetylation link mechanistically unestablished (contribution_context, reporting_reproducibility, scientific_validity).
• Unquantified immunoblot densitometry, lentiviral transduction efficiency, and imaging quantification thresholds across multiple figures (data_analysis, reporting_reproducibility).
• Incomplete public deposition: full TMT proteome dataset accession and Addgene plasmid IDs not yet available (reporting_reproducibility).
• Overlap with concurrent work (Ko et al. 2024) not clearly delineated (contribution_context).